| Financial Year |
March 31 2023 |
| Monetary Funds |
424,878,906.65 |
| Held-for-trading Financial Assets |
2,705,003.95 |
| Notes Receivable |
8,786,068.51 |
| Accounts Receivable |
1,357,318,085.17 |
| Advances to Suppliers |
154,571,022.40 |
| Other Receivables |
45,872,223.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,701,330,185.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
85,651,239.77 |
| Total Current Assets |
3,790,582,939.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,117,918,726.04 |
| Under-construction Projects |
268,311,358.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
75,867,716.98 |
| R&D expenses |
-- |
| Goodwill |
27,135,800.27 |
| Long-Term Deferred and Prepaid Expenses |
53,772,044.85 |
| Deferred Income Tax Assets |
7,319,170.88 |
| Other Non-Current Assets |
45,932,134.33 |
| Sub-Total of Non-Current Assets |
1,606,488,893.56 |
| Total Assets |
5,397,071,833.46 |
| Short-Term Loans |
100,109,408.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
745,448,558.34 |
| Accounts Payable |
373,390,465.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
214,431,783.44 |
| Taxes Payable |
26,551,349.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
11,450,658.54 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,943,619.39 |
| Other Current Liabilities |
5,885,684.96 |
| Sub-Total of Current Liabilities |
1,589,272,730.48 |
| Long-term Loans |
511,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
26,100,835.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
542,174,398.57 |
| Total Liabilities |
2,131,447,129.05 |
| Paid-In Capital(Or Share Stock) |
652,190,511.00 |
| Capital Surplus |
975,551,573.85 |
| Surplus Reserve |
270,033,022.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,367,849,597.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,265,624,704.41 |
| Owner's Equity（Stockholder's Equity） |
3,265,624,704.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,397,071,833.46 |
